Obesity & Cancer Symposium

ANNOUNCEMENT

Symposium Start Date
25
June 2026

ANNOUNCEMENT

Symposium End Date
28
June 2026

Committees

Prof. M. Mahir ÖZMEN

Symposium Honorary-President

Prof. Cihan URAS

Symposium President

Assoc. Prof. Emir ÇAPKINOĞLU

Symposium Secretary

ORGANIZING COMMITTEE

Cem Kaan PARSAK

Cihan URAS

Erdal Birol BOSTANCI

Emir ÇAPKINOĞLU

Mehmet Mahir OZMEN

Tahsin ÇOLAK

*The Organizing Committee members are listed in alphabetical order by name.

INTERNATIONAL FACULTY

Prof. Asim SHABBIR

Singapore

Prof. Gerald DAVID

Prof. Gianfranco SILECCHIA

Italy

Prof. Jim KHAN

Prof. Kazunori KASAMA

Japan

Prof. Takahiro KINOSHITA

Japan

Prof. Zaman Z. MAMEDLİ

Russia

*The International Faculty members are listed in alphabetical order by name.

NATIONAL FACULTY

Ahmet RENÇÜZOĞULLARI
Ali DURAN
Aras Emre CANDA
Barış ZULFİKAROĞLU
Cem Kaan PARSAK
Cihan URAS
Dursun BUĞRA
E. Birol BOSTANCI
Emir ÇAPKINOĞLU
Emre BALIK
Emre HURİ
Erdinç KAMER
Evren DİLEKTAŞLI
Gürhan SAKMAN
Halil ÖZGÜÇ
Hilmi BOZKURT
İlkan TATAR
İlknur TURAN
M Cem TERZİ
M Kadri ÇOLAKOĞLU
M Mahir ÖZMEN
M. Tahir ORUÇ

İsmail Cem ERAY
Metin ERTEM
Mustafa ATABEY
Nidal İFLAZOĞLU
Nihat AKSAKAL
Orçun YALAV
Ömer YOLDAŞ
Özgen IŞIK
Özgül DÜZGÜN
Özlem SÖNMEZ
Recep AKTİMUR
Samet YARDIMCI
Servet Sezgin ULUDAĞ
Sezer BULUT
Sibel GELECEK
Süleyman ÇETİNKÜNAR
Tahsin ÇOLAK
Tolga DİNÇ
Turgut KARACA
Varlık EROL
Yılmaz ÖZDEMİR
Zafer TEKE

*The National Faculty members are listed in alphabetical order by name.

Kazunori KASAMA

Kazunori Kasama, MD　

Director, Weight Loss and Metabolic Surgery Center, Yotsuya Medical Cube

Graduated from Gunma University, School of Medicine 1990 Japan　

Professional Experience

1990 Dept of Anesthesiology,　Gunma University
1993 Dept of Traumatology and Emergency medicine, Osaka University
1994 Senior Resident, Dept of Surgery, Kameda Medical Center
1997 Staff, Dept of surgery, Kameda Medical Center
2000 Assistant Director, Dept of Surgery, Kameda Medical Center
2001 Director, Dept of Surgery, Horie Hospital
2006 Director, Dept of Weight Loss Surgery, Minimally Invasive Surgery Center, Yotsuya Medical Cube.
2011 Director, Weight Loss and Metabolic Surgery center, Yotsuya Medical Cube.

Past President of International Federation of Surgery for Obesity and Metabolic Disorder: Asian Pacific Chapter. (IFSO-APC)
Past President of Asia Pacific Metabolic and Bariatric Surgery Society (APMBSS)
Treasurer of ELSA (Endoscopic and Laparoscopic Surgeons of Asia)

Vice President, Executive board of Japan Society of Treatment for Obesity (JSTO)
President of Japan Consortium of Endoscopic Obesity and Metabolic Surgery (JCOMS)

Honorary Member of Venezuelan Society of Bariatric and Metabolic Surgery,
Honorary Member of Indonesian Society of Endoscopic Surgery
Honorary Member of Chinese Society of Metabolic and Bariatric Surgery
Honorary Member of OSSI (Obesity Surgery Society of India)
Board member of International Bariatric Club (IBC) etc

Jim Khan (UK)

Professor Jim S Khan

MBBS, MSc, PhD, FRCS(Glasg) , FCPS (Surg), FRCS (Gen & Colorectal Surgery)
Consultant Laparoscopic, Robotic and Colorectal Surgeon
National & European Trainer in Robotic &Laparoscopic Surgery
Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth, UK
Professor of Surgery, University of Portsmouth, UK

Research Gate index 34.24
h-index 37
i-10 index 95
citations 8378
Over 270 publications (book chapters, peer reviewed papers & abstracts)
https://scholar.google.com/citations?user=2LOwSU4AAAAJ&hl=en&oi=ao

Work History:

June 2020 to date Professor of Surgery, University of Portsmouth
August 2008 – to present date Consultant Laparoscopic Colorectal & General Surgeon Clinical Director & lead for colorectal cancer Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Cosham, Portsmouth
December 2008 to January 2009 Visiting Clinical Fellow, The Mayo Clinic, Rochester, USA
October 2008 to November 2008 Senior Registrar, Gen Surgery, Southampton General Hospital
April 2008 to September 2008 Laparoscopic Colorectal Fellow, Colchester University Hospital

Key Publications:

The Impact of a Modular Robotic Total Mesorectal Excision Training Program on Perioperative and Oncological Outcomes in Robotic Rectal Cancer Surgery. S Stefan, GN Piozzi, P Tejedor, CCL Liao, A Ahmad, NZ Ahmad, ... J Khan. Diseases of the Colon & Rectum 67 (11), 1485-1494
Laparoscopic and robotic total mesorectal excision in overweight and obese patients: multinational cohort study. BP Smalbroek, RTJ Geitenbeek, LM Dijksman, J Khan, Q Denost, ...British Journal of Surgery 111 (10), znae259
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open …SP Bach, A Gilbert, K Brock, S Korsgen, I Geh, J Hill, T Gill, P Hainsworth, Jim Khan... The lancet Gastroenterology & hepatology 6 (2), 92-105
An Institutional Shift from Routine to Selective Diversion of Low Anastomosis in Robotic TME Surgery for Rectal Cancer Patients Using the KHANS Technique: A Single-Centre …R Duhoky, GN Piozzi, MLW Rutgers, I Mykoniatis, N Siddiqi, S Naqvi, ...J Khan. Journal of Personalized Medicine 14 (7), 725
Robotic complete mesocolic excision with central vascular ligation for right colonic tumours—a propensity score-matching study comparing to standard laparoscopy JS Khan1,2, A Ahmad3, M Odermatt4, DG Jayne5, NZ Ahmad3, N Kandala6, NP West7. BJS Open 2021.
The impact of robotic total mesorectal excision on survival of patients with rectal cancer-a propensity matched analysis. Tejedor P, Sagias F, Flashman K, Lee YH, Naqvi S, Kandala N, Khan J. Int J Colorectal Dis. 2019 Dec;34(12):2081-2089. doi: 10.1007/s00384-019-03417-9. Epub 2019 Nov 11.
Robotic rectal surgery has advantages over laparoscopic surgery in selected patients and centres. Khan JS, Banerjee A, Kim SH, Rockall T, Jayne D. Colorectal Dis. 2018 August 12 doi: 10.1111/codi.14367
Robotic Lateral Pelvic Lymph Node Dissection For Rectal Cancer. P Tejedor, F Sagias, S Naqvi, JS Khan. Accepted in Tech Coloprcotology. October 2018.
Positional complications of minimal access surgery (MIS)Laparoscopic/ robotic/transanal surgery. Waqas A, Arulampalam T, Naqvi S, Khan J. Colorectal Dis. 2018 Mar 4. doi: 10.1111/codi.14061.
Colorectal cancer surgery in the very elderly patient: a systematic review of laparoscopic versus open colorectal resection. Int J Colorectal Dis. 2017 Jun 30. doi: 10.1007/s00384-017-2848-y. Devoto L, Celentano V, Cohen R, Khan J, Chand M.

Research Grants:

PI of 10 national and international trials including, HiP, TREC, CIPHER, ESCP, RESET, MIRCAST, FILTER, DAMASCUS, COMET, Rolacart Have successfully secured various grants over the years covering robotic surgery, outcomes, training and simulation.

Students Supervised:

MRes/MSc 10
PhD 5

Key Positions:

President in waiting of the Association of Coloproctology of Great Britain and Ireland ACPGBI
FRCS examiner since 2015
European trainer and proctor in Robotic Colorectal Surgery
Association of Laparoscopic Surgeons (ALSGBI) – robotic advisory group member and national council member, Director of Research
European Society of Coloproctology (ESCP) – fellow and member of the core-working group on training in robotic surgery
Council member and trustee of the British Association of Surgical Oncology (BASO)
Board member ESSO (European Society of Surgical Oncology)
Regional advisor South, The Royal College of Physicians & Surgeons Glasgow (RCPSG), Co-opted council member for robotic surgery at the RCPSG
Core member Robotic Research Committee, The Royal College of Surgeons of England, Colorectal lead for RADAR group at RCS
Member of education committee of American Society of Colon & Rectal Surgeons
Visiting and Honorary consultant surgeon to over 20 other hospitals
Faculty of surgical trainers, RCSEd Edinburgh
NICE – Member of the advisory committee on pelvic floor surgery & technology appraisal

MIS Surgery Experience:

Over 2500 MIS colorectal procedures with excellent outcomes
>1000 robotic colorectal procedures
Pioneer in robotic CME and robotic LPLND and Robot Exenteration work in the UK
Robotic train the trainer courses and basic and advanced robotic training courses director.

Zaman Z. Mamedli, MD, DMCs

Zaman Z. Mamedli

Mail: z.z.mamedli@gmail.com
phone: +79264678988
Moscow, Russian Federation 26.07.1974
https://www.ronc.ru/about/struktura/niiko/ao3/

Organisations

Russian Society of Colorectal Cancer, Сhairman of the board 2019 – Present
Society develop and manage guidlines for colorectal cancer treatment for Ministry Russian Federation
of Health. Also annual congress for colorectal surgery and oncology organize by the
Society and in 2025 it will be 27-29 of November
Professional Experience

Professional Experience

Chief of colorectal surgery dept, Russian cancer Research Center      2018 – Present
Biggest cancer center in Russia with 900 adult and 250 chield beds. Depertment of      Moscow, Russian
colorectal cancer is a 50 beds dept. 1500 surgeries done for last year.      Federation
Experienced Surgeon with a proven track record of excellence in performing
complex surgical procedures. Skilled in diagnosing and treating various medical
conditions, utilizing advanced medical technologies and techniques to ensure
optimal patient outcomes. Highly effective communicator, adept at collaborating
with interdisciplinary healthcare teams to provide comprehensive patient care.
Committed to delivering compassionate and patient-centered care while adhering to the highest professional and ethical standard

Attending surgeon, Russian Cancer Research Center    2011 – 2018

Perform complex surgical procedures with a high level of expertise and precision Moscow, Russian
Lead and guide a team of surgical staff, including resident doctors and nurses, during surgeries Federation
Develop and implement surgical treatment plans for patients based on their medical conditions

Resident in surgical oncology, Russian Cancer Research Center

2006 – 2011 Moscow, Russian
Federation

Fellowship in surgery, AKH, Vienna University Hospital

2004 – 2006
Vienna, Austria

Surgical resident, Shagra General Hospital

2000 – 2004
Ar-Riyadh, Kingdom of
Saudi Arabia

Resident in surgery, Hospital of internal troops under Ministry of Internal Affairs

1996 – 2000
Baku, Azerbaijan

Skills

Education

Azerbaijan State Medical University

1990 – 1996
Baku, Azerbaijan

Languages

azeri, russian, english, arabic

Profile

Takahiro KINOSHITA

Current affiliation: Gastric Surgery Division, National Cancer Center Hospital East, Japan

Position: Chief Director

Mailing address (office): 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan

Phone (office): +81-4-7133-1111

E-mail: takkinos@east.ncc.go.jp

Date of birth: April 24th 1969

Nationality: Japanese

Languages: Japanese, English and German

Medical educations:

1994.3 Graduated from Kanazawa University School of Medicine (MD)
1999.3 Graduated from Kanazawa University Graduate School of Medicine (PhD)

Surgical practices:

1994.4 ~ 2001.6 Department of Surgery, Kanazawa University, and related hospitals
2001.7 ~ 2003.1 Division of Minimal Invasive Surgery, Department of General Surgery, Eberhard-Karls University of Tuebingen (Germany)

Awards:

2001-2002 German Academic Exchange Service (DAAD)
2008 Best poster presentation in world congress of endoscopic surgery
2015 Academic research fund of Japanese Gastric Cancer Association
2015 Research fund of Novartis Pharma

Clinical positions as staff surgeon after practices:

2003.2 ~ 2004.3 Head Surgeon, Department of Surgery, Tsuruga Municipal Hospital
2004.4 ~ 2010.8 Associate Professor, Department of Surgery, Toho University Sakura Medical Center Hospital
2010.9 ~ 2012.6 Head Surgeon, Gastric Surgery Division, Department of Surgical Oncology, National Cancer Center Hospital East
2012.7 ~ Chief Director, ditto
2023.4~ Visiting Professor, Saitama Medical University

Special fields:

Gastric surgery, Surgical oncology, Laparoscopic surgery, Robotic surgery

Scientific focus:

Multidisciplinary and personalized cancer treatment, Less invasive cancer treatment

Live demonstration laparoscopic gastric cancer surgeries in foreign countries:

2011.1 Daramushira Cancer Center (Delhi, India)
2012.4 Tianjin Union Medical Center (Tianjin, China)
2012.7 VietDuc Hospital (Hanoi, Vietnam)
2014.7, 2017.1 Qingdao University Hospital (Qingdao, China)
2014.9 Henan Provincial People’s Hospital (Zhengzhou, China)
2014.11 Southern Medical University Hospital (Guangzhou, China)
2015.1 China-Japan Hospital (Beijing, China)
2015.11 Xian Jiaotong University Hospital (Xian, China)
2016.4 Sun Yat-Sen Memorial Hospital (Guangzhou, China)
2016.6, 2017.4 Beijing University Cancer Hospital (Beijing, China)
2016.6 N.N. Petrov Scientific Oncology Institution (St. Petersburg, Russia)
2016.6 Moscow Oncology Hospital #62 (Moscow, Russia)
2017.7 Jilin University Hospital (Changchun, China)
2017.7 National Cancer Hospital (Hanoi, Vietnam)
2018.6 Central Military Hospital 108 (Hanoi, Vietnam)
2018.11 Cho Ray Hospital (Hanoi, Vietnam)
2019.5 Hangzhou Cancer Center Hospital (Hangzhou, China)
2019.8 Max Hospital (New Delhi, India)
2019.10 Beijing Friendship Hospital (Beijing, China)
2019.11 Tang Gu Hospital (Xian, China)
2019.12 Cangzhou People’s Hospital (Cangzhou, China)

Membership of medical society:

Fellowship of American College of Surgeons (FACS)
Japan Surgical Society (Board Certified Surgeon)
The Japanese Society of Gastrointestinal Surgery (Board Member, Board Certified Surgeon, International Affairs Commitee)
Japan Society for Endoscopic Surgery (Board Certified Surgeon, Skill-qualified Surgeon)
Japan Gastroenterological Endoscopic Society (Board Certified Doctor)
Japanese Gastric Cancer Association (Director, Chairman of COI Committee, Chairman of Educational Committee, Member of JGCA Treatment Guideline Editorial Committee)
Japanese Robotic Surgery Association (Board Certified Member)
Japanese Society for Gastro-surgical Pathophysiology (Board Certified Doctor)
Japan Clinical Oncology Group (JCOG) (Scientific Core Member)
European Association for Endoscopic Surgery (EAES)
Upper GI International Robotic Association (UGIRA) (Senior Member)
Honorable Member of Peruvian Surgical Society

Editorial Boards:

Gastric Cancer (Springer)

Lectures abroad (out of East Asia)

Transhiatal vs Transthoracic Esophagectomy. ESSO Webinar on Technical Aspects and Innovations in Upper GI Cancer. 2023.9.14. Italy (Online)
Case Discussion 2 - Adenocarcinoma of the esophagogastric junction. BCDS/JSGS Joint Webinar, Brazilian Digestive Week Congress. 2022.12.2 Brazil (Online)
Case Presentation: Esophatogastric Junction Cancer. The first joint webinar of BCDS and JSGS. 2022.1.29, Brazil (Online)
Laparoscopic Surgery for Gastric Cancer. Russia-Japan Oncology Educational Project Webinar on Laparoscopic Surgery for Gastric Cancer. 2022.1.20. Russia (Online)
Troubleshooting in Minimally Invasive Gastrectomy. TUMS Minimally Invasive Surgical Oncology Congress, Tehran. 2021.2.5. Islamic Republic of Iran (Online)
Laparoscopic D2 Gastrectomy. EICC-BCS 2020. 2020.12.26. India (Online)
Minimally Invasive Surgery in Type II Cardia Cancer: Approach and Results. 13th International Gastric Cancer Congress (IGCC2019). 2019.5.9, Praha, Czech Republic
Standard D2 Dissection of Laparoscopic Gastrectomy. 16th International Congress of General Surgery. 2019.3.28, Lima, Peru
Laparoscopic Transhiatal Resection of EGJ Cancer. 16th International Congress of General Surgery. 2019.3.28, Lima, Peru
Robotic Surgery for Gastric Cancer. 16th International Congress of General Surgery. 2019.3.28, Lima, Peru
How to manage intraoperative complication in the laparoscopic radical surgery. 16th International Congress of General Surgery. 2019.3.28, Lima, Peru
Current evidences and status of laparoscopic surgery for gastric cancer. 16th International Congress of General Surgery. 2019.3.28, Lima, Peru
Updated guidelines of surgical treatment for gastric cancer in Japan. Workshop on updates in laparoscopic gastrectomy for treatment of gastric cancer. 2018.11.3, Ho Chi Min, Vietnam
Techniques and results of laparoscopic gastrectomy for gastric cancer. Workshop on updates in laparoscopic gastrectomy for treatment of gastric cancer. 2018.11.3, Ho Chi Min, Vietnam
Laparoscopic stomach resection or gastrectomy: how I do it (video). 4th St. Petersburg International Oncology Forum. 2018.7.5, St. Petersburg, Russia
Laparoscopic surgery for locally advanced gastric and esophagogastric junction cancer. 4th St. Petersburg International Oncology Forum. 2018.7.5, St. Petersburg, Russia
Advances in Endoscopic Surgery for the Treatment of Gastric Cancer. Gastrointestinal Live Surgery Workshop. 2018.6.16, Hanoi, Vietnam
Discover the Unique Clinical Benefits of the ENDOEYE 3D Imaging System and THUNDERBEAT Type S. EAES2018. 2018.5.31, London, UK
MAS for gastric malignancies (joint with JSES): How I do it: MAS gastrectomy. EAES2018. 2018.5.31, London, UK
Masterclass: MC4 Quality of Thoraco/laparoscopic clearance of lymph nodes in UGI cancer surgery: Lymphadenectomy for gastric cancer in the East. EAES2018. 2018.5.30, London, UK
Laparoscopic radical gastrectomy for advanced gastric cancer. 20th congress of Russian society for endoscopic surgery. 2017.4.6, Moscow, Russia
Laparoscopic gastric cancer surgery in Japan. R&D/GSM Learning Session. 2018.4.13, Cincinnati, US
Robotic surgery for gastric cancer. Saudi Laparoscopic Society Annual Congress 2018. 2018.3.1, Riyadh, Saudi Arabia
Video presentation: Laparoscopic surgery for advanced gastric cancer. Saudi Laparoscopic Society Annual Congress 2018. 2018.3.1, Riyadh, Saudi Arabia
Panel discussion: Best approach for advanced gastric cancer (Robotic/ laparoscopic/ open). Saudi Laparoscopic Society Annual Congress 2018. 2018.3.1, Riyadh, Saudi Arabia
Overview on Gastric Cancer Surgery Today. 8th International Advanced Workshop On Minimally Invasive Digestive Surgery. 2018.2.9, Singapore
27. D2 Lymphadenectomy and Reconstruction Technique. 8th International Advanced Workshop On Minimally Invasive Digestive Surgery. 2018.2.9, Singapore
Current status of laparoscopic gastric cancer surgery in Japan. Laparoscopic Gastrectomy Workshop. 2017.7.4, Hanoi, Vietnam
Intracorporeal anastomosis using linear staplers in laparoscopic gastrectomy. Laparoscopic Gastrectomy Workshop. 2017.7.4, Hanoi, Vietnam
Modern Surgery for gastric cancer in Japan. II St. Petersburg Oncology Forum "White nights". 2016.6.21, St. Petersburg, Russia
Technical aspects of laparoscopic surgery for gastric cancer: a step-by-step. 2016 LADG Workshop Russia, Moscow Oncology Hospital #62. 2016.6.22, Moscow, Russia

Publication lists (Current-2010)

Kinoshita T, Akimoto E, Yura M, Yoshida M. Survival outcomes of laparoscopic versus open total gastrectomy with nodal dissection for gastric cancer in a high-volume Japanese center: A propensity score-matched analysis. Ann Gastroenterol Surg. 2023;7(1):53-62.
Kinoshita T, Sato R, Akimoto E, Tanaka Y, Okayama T, Habu T. Reduction in postoperative complications by robotic surgery: a case–control study of robotic versus conventional laparoscopic surgery for gastric cancer. Surg Endosc. 2022;36(3):1989-1998. doi: 10.1007/s00464-021-08483-1. Epub 2021 Apr 12.
Kinoshita T, Sato R, Akimoto E, Yoshida M, Harada J, Nishiguchi Y. Can laparoscopic spleen-preserving splenic hilar lymph node dissection replace prophylactic splenectomy for proximal advanced gastric cancers that invade the greater curvature? Eur J Surg Oncol. 2021;47(6):1466-1472.
Kinoshita T, Okayama T. Is splenic hilar lymph node dissection necessary for proximal gastric cancer surgery? Ann Gastroenterol Surg. 2020;5(2):173-182.
Kinoshita T. Minimally invasive approaches for early gastric cancer in East Asia: current status and future perspective. Transl Gastroenterol Hepatol. 2020;5:20.
Kinoshita T, Honda M, Matsuki A, Enomoto N, Aizawa M, Nunobe S, et al. Billroth-I vs Roux-en-Y after distal gastrectomy: A comparison of long-term nutritional status and survival rates from a large-scale multicenter cohort study. Ann Gastroenterol Surg. 2020;4(2):142-50.
Kinoshita T, Uyama I, Terashima M, Noshiro H, Nagai E, Obama K, Tamamori Y, Nabae T, Honda M, Abe T; LOC-A Study Group. Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage II/III Gastric Cancer: A Multicenter Cohort Study in Japan (LOC-A Study). Ann Surg. 2019;269(5):887-94.
Kinoshita T, Kaito A. Current status and future perspectives of laparoscopic radical surgery for advanced gastric cancer. Transl Gastroenterol Hepatol. 2017;2(5).
Kinoshita T, Tokunaga M, Kaito A. How I do it: technical tips of laparoscopic surgery for advanced gastric cancer. Ann Laparosc Endosc Surg. 2017;2(11).
Kinoshita T, Shibasaki H, Enomoto N, Sahara Y, Sunagawa H, Nishida T. Laparoscopic splenic hilar lymph node dissection for proximal gastric cancer using integrated three-dimensional anatomic simulation software. Surg Endosc. 2016;30(6):2613-9.
Kinoshita T. Splenic hilar dissection in the treatment of proximal advanced gastric cancer: what is an adequate strategy? Transl Gastroenterol Hepatol. 2016;1(7).
Kinoshita T. Technical tips of laparoscopic linear-stapled esophagojejunostomy (overlap method). Ann Laparosc Endosc Surg. 2016;1(7).
Kinoshita T, Kinoshita T, Saiura A, Esaki M, Sakamoto H, Yamanaka T. Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg. 2015;102(1):102-7.
Kinoshita T, Gotohda N, Kato Y, Takahashi S, Konishi M, Kinoshita T. Laparoscopic proximal gastrectomy with jejunal interposition for gastric cancer in the proximal third of the stomach: a retrospective comparison with open surgery. Surg Endosc. 2013;27(1):146-53.
Kinoshita T, Gotohda N, Kato Y, Takahashi S, Konishi M, Okazumi S, Katoh R, Kinoshita T. Laparoscopic Transhiatal Resection for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: Operative Technique and Initial Results. Surg Laparosc Endosc Percutan Tech. 2012;2(4):E199-E203.
Kinoshita T, Shibasaki H, Oshiro T, Ooshiro M, Okazumi S, Katoh R. Comparison of laparoscopy-assisted and total laparoscopic Billroth-I gastrectomy for gastric cancer: a report of short-term outcomes. Surg Endosc. 2011;25(5):1395-401.
Mitsui T, Mori A, Takamatsu T, Kadota T, Sato K, Fukushima R, Okubo K, Umezawa M, Takemura H, Yokota H, Kuwata T, Kinoshita T, Ikematsu H, Yano T, Maeda S, and Soga K. Evaluating the identification of the extent of gastric cancer by over-1000 nm near-infrared hyperspectral imaging using surgical specimens. J. Biomed. Opt. 22 August 2023, Published Online.
Komatsu M, Kinoshita T, Akimoto E, Yoshida M, Nagata H, Habu T, Okayama T, Yura M. Advantages of robotic gastrectomy for overweight patients with gastric cancer: a comparison study of robotic gastrectomy and conventional laparoscopic gastrectomy. Surg Today. 6 April 2023. Published Online. https://doi.org/10.1007/s00595-023-02681-1
Etoh T, Ohyama T, Sakuramoto S, Tsuji T, Lee SW, Yoshida K, Koeda K, Hiki N, Kunisaki C, Tokunaga M, Otsubo D, Takagane A, Misawa K, Kinoshita T, Cho H, Doki Y, Nunobe S, Shiraishi N, Kitano S; for the Japanese Laparoscopic Surgery Study Group (JLSSG). Five-Year Survival Outcomes of Laparoscopy-Assisted vs Open Distal Gastrectomy for Advanced Gastric Cancer The JLSSG0901 Randomized Clinical Trial. JAMA Surg. 2023;(158(5):445-454
Akimoto E, Kuwata T, Shitara K, Kawazoe A, Sakamoto N, Ishii G, Ochiai A, and Kinoshita T. The impact of programmed death-ligand 1 expression on mismatch repair deficiency and Epstein-Barr virus status on survival outcomes in patients with stage II/III gastric cancer after surgery. Ann Surg Oncol. 2023;30(8):5227-5236
Habu T, Kumanishi R, Ogata T, Fujisawa T, Mishima S, Kotani D, Kadowaki S, Nakamura M, Hojo H, Fujiwara H, Kumagai S, Koyama S, Fujita T, Kinoshita T, Nishikawa H, Yano T, Tajika M, Muro K, Mitsunaga S, Kojima T & Bando H. Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma. Esophagus. 2023;20(3)8:533-540
Sakashita S. Sakamoto N, Kojima M, Taki T, Miyazaki S, Minakata N, Sasabe M, Kinoshita T, Ishii G & Ochiai A. Requirement of image standardization for AI-based macroscopic diagnosis for surgical specimens of gastric cancer. Journal of Cancer Research and Clinical Oncology. 2023;149(9):6467-6477
Yamaguchi T, Takashima A, Nagashima K, Kumagai K, Yamada T, Terashima M, Yabusaki H, Nishikawa K, Tanabe K, Yunome G, Kawachi Y, Yamada T, Fukagawa T, Kinoshita T, Watanabe M, Ishiyama K, Inoue K & Boku N. Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study. Gastric Cancer. 2023;26(2):307-316.
Mizusawa J, Tokunaga M, Machida N,Yabusaki H, Kawabata R, Imamura H, Kinoshita T, Nomura T, Nunobe S, Tsuji K, Katayama H, Fukuda H, Boku N,Yoshikawa T, Terashima M and Stomach Cancer Study Group of the Japan Clinical Oncology Group. Protocol digest of a phase III trial to evaluate the efficacy of preoperative chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with postoperative S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA Trial). Jpn J Clin Oncol. 2023;53(2):168-173.
Komatsu M, Kinoshita T, Akimoto E, Yoshida M, Terajima D, Nagat H, Habu T, Okayama T, Takabe Y, Yura M. Feasibility and Safety of Robot-Assisted Total Gastrectomy With D2 Lymph Node Dissection for Gastric Cancer. Ann Surg. 2023; 277(3):420-427.
Akimoto E, Kinoshita T, Sato R, Yura M, Harada J, Yoshida M, Okayama T, Takabe Y, Tanaka Y, Tomi Y, Habu T. Impact of postoperative intra-abdominal infectious complications on survival outcomes in patients with gastric cancer who underwent laparoscopic surgery. Surg Endosc. 2023;37(1):382-390.
Kanda M, Terashima M, Kinoshita T, Yabusaki H, Tokunaga M, Kodera Y. A multi-institutional study to evaluate the feasibility of next-generation sequencing and genomic analysis using formalin-fixed, paraffin-embedded biopsies of gastric cancer. Gastric Cancer. 2023;26(1):108-115.
Hasegawa H, Shitara K, Takiguchi S, Takiguchi N, Ito S, Kochi M, Horinouchi H, Kinoshita T, Yoshikawa T, Muro K, Nishikawa H, Suna H, Kodea Y. A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer. Gastric Cancer. 2022;25(3):619-628.
Shogo Kumagai, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, Kamada T, Irie T, Okumura G, Kono H, Ito D, Fujii R, Watanabe S, Sai A, Fukuoka S, Sugiyama E, Watanabe G, Owari T, Nishinakamura H, Sugiyama D, Maeda Y, Kawazoe A, Yukami H, Chida K, Ohara Y, Yoshida T, Shinno Y, Takeyasu Y, Shirasawa M, Nakama K, Aokage K, Suzuki J, Ishii G, Kuwata T, Sakamoto N, Kawazu M, Ueno T, Mori T, Yamazaki N, Tsuboi M, Yatabe Y, Kinoshita T, Doi T, Shitara K, Mano H, Nishikawa H. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40:201-218.
Tanaka Y, Kinoshita T, Akimoto E, Sato R, Yura M, Harada J, Yoshida M, Tomi Y. The impact of hiatal hernia on survival outcomes in patients with gastroesophageal junction adenocarcinoma. Ann Gastroenterol Surg. Online. 2021.12.
Sasaki K, Kobayashi S, Kudo M, Sugimoto M, Takahashi S, Nakamura Y, Kawazoe A, Shitara K, Kinoshita T, Gotohda N. Hypothyroidism and hypopituitarism as immune-related adverse events due to lenvatinib plus pembrolizumab therapy in the immediate postoperative period after laparoscopic hepatectomy for liver metastases from gastric cancer: a case report. Surg Case Rep. 7:267, Online. 2021.
Tokunaga M, Yoshikawa T, Boku N, Nishida Y, Tanahashi T, Yamada T, Haruta S, Etoh T, Hirahara N, Kawachi Y, Tsuji K, Kinoshita T, Kanazawa T, Tokumoto N, Fujita J, Terashima M. Impact of COVID-19 on gastric cancer treatment in Japanese high-volume centers: a JCOG stomach cancer study group survey. Surgery Today. 2022;52(2):231-238.
Ikematsu H, Ishihara M, Okawa S, Minamide T, Mitsui T, Kuwata T, Ito M, Kinoshita T, Fujita T, Yano T, Omori T, Ozawa S, Murakoshi D, Irisawa K, Ochiai A. Photoacoustic imaging of fresh human surgically and endoscopically resected gastrointestinal specimens. DEN Open. 2022;2:e28, Online. 2021.
Akimoto E, Tokunaga M, Sato R, Yoshida A, Naito Y, Yamashita R, Kinoshita T, Kuwata T. Gastric mesenchymal tumor with smooth muscle differentiation and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion. Pathol. Int. 2021.
Ishii T, Suzuki A, Kuwata T, Hisamitsu S, Hashimoto H, Ohara Y, Yanagihara K, Mitsunaga S, Yoshino T, Kinoshita T, Ochiai A, Shitara K, Ishii G. Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy. Gastric Cancer. 2021.4.
Sato R, Kinoshita T, Akimoto E, Yoshida M, Nishiguchi Y, Harada J. Feasibility and quality of life assessment of laparoscopic proximal gastrectomy using double-tract reconstruction. Langenbecks Arch Surg. 2021;406(2):479-89.
Sugita S, Kinoshita T, Kuwata T, Tokunaga M, Kaito A, Watanabe M, Tonouchi A, Nagino M. Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type II adenocarcinoma of the esophagogastric junction. Surg Endosc. 2021;35(1):340-8.
Watanabe M, Kuwata T, Setsuda A, Tokunaga M, Kaito A, Sugita S, Tonouchi A, Kinoshita T, Nagino M. Molecular and pathological analyses of gastric stump cancer by next-generation sequencing and immunohistochemistry. Sci Rep. 2021;11(1):4165.
Yang HK, Ji J, Han SU, Terashima M, Li G, Kim HH, Law S, Shabbir A, Song KY, Hyung WJ, Kosai NR, Kono K, Misawa K, Yabusaki H, Kinoshita T, Lau PC, Kim YW, Rao JR, Ng E, Yamada T, Yoshida K, Park DJ, Tai BC, So JBY, on behalf of the EXPEL study group. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2021;6(2):120-7.
Yamaguchi T, Takashima A, Nagashima K, Makuuchi R, Aizawa M, Ohashi M, Tashiro K, Yamada T, Kinoshita T, Hata H, Kawachi Y, Kawabata R, Tsuji T, Hihara J, Sakamoto T, Fukagawa T, Katai H, Higuchi K, Boku N. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study. Ann Surg Oncol. 2020;27(1):284-92.
Yamaguchi T, Takashima A, Nagashima K, Terashima M, Aizawa M, Ohashi M, Tanaka R, Yamada T, Kinoshita T, Matsushita H, Ishiyama K, Hosoda K, Yuasa Y, Haruta S, Kakihara N, Nishikawa K, Yunome G, Satoh T, Fukagawa T, Hitoshi Katai H, Boku N. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study. Gastric Cancer. 2020.
Akimoto E, Kinoshita T, Sato R, Yoshida M, Nishiguchi Y, Harada J. Feasibility of laparoscopic total gastrectomy with splenectomy for proximal advanced gastric cancer: A comparative study with open surgery. Asian J Endosc Surg. 2020.
Haga Y, Hiki N, Kinoshita T, Ojima T, Nabeya Y, Kuwabara S, Seto Y, Yajima K, Takeuchi H, Yoshida K, Kodera Y, Fujiwara Y, Baba H. Treatment option of endoscopic stent insertion or gastrojejunostomy for gastric outlet obstruction due to gastric cancer: a propensity score-matched analysis. Gastric Cancer. 2020;23(4):667-76.
Harada J, Kinoshita T, Sato R, Akimoto E, Yoshida M, Nishiguchi Y. Delta-shaped gastroduodenostomy after totally laparoscopic distal gastrectomy for gastric cancer: comparative study of original and modified methods. Surg Endosc. 2020.
Kumagai S, Togashi Y, Sakai C, Kawazoe A, Kawazu M, Ueno T, Sato E, Kuwata T, Kinoshita T, Yamamoto M, Nomura S, Tsukamoto T, Mano H, Shitara K, Nishikawa H. An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells. Immunity. 2020;53(1):187-203 e8.
Ri M, Nunobe S, Honda M, Akimoto E, Kinoshita T, Hori S, Aizawa M, Yabusaki H, Isobe Y, Kawakubo H, Abe T. Gastrectomy with or without omentectomy for cT3-4 gastric cancer: a multicentre cohort study. Br J Surg. 2020;107(12):1640-7.
Sato D, Takamatsu T, Umezawa M, Kitagawa Y, Maeda K, Hosokawa N, Okubo K, Kamimura M, Kadota T,Akimoto T, Kinoshita T, Yano T, Kuwata T, Ikematsu H, Takemura H, Yokota H & Soga K. Distinction of surgically resected gastrointestinal stromal tumor by near-infrared hyperspectral imaging. Sci Rep. 2020;10(1):21852.
Sugita S, Kinoshita T, Kuwata T, Tokunaga M, Kaito A, Watanabe M, Tonouchi A, Sato R, Nagino M. Intramucosal-lymphatic invasion has a slight impact on lymph node metastasis in patients with early gastric cancer. Surg Today. 2020;50(5):484-9.
Kuwata T, Yanagihara K, Iino Y, Komatsu T, Ochiai A, Sekine S, Taniguchi H, Katai H, Kinoshita T, Ohtsu A. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts. Cells. 2019;8(6).
Takahashi K, Yoshikawa T, Morita S, Kinoshita T, Yura M, Otsuki S, Tokunaga M, Yamagata Y, Kaito A, Katai H. Different risks of nodal metastasis by tumor location in remnant gastric cancer after curative gastrectomy for gastric cancer. Gastric Cancer. 2020;23(1):195-201.
Tonouchi A, Sugano M, Tokunaga M, Sugita S, Watanabe M, Sato R, Kaito A, Akimoto T, Ochiai A, Kinoshita T, Kuwata T. Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer. World J Surg. 2019;43(10):2499-505.
Uyama I, Suda K, Nakauchi M, Kinoshita T, Noshiro H, Takiguchi S, Ehara K, Obama K, Kuwabara S, Okabe H, Terashima M. Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: a multi-institutional prospective single-arm study. Gastric Cancer. 2019;22(2):377-85.
Takeuchi M, Kawakubo H, Abe Y, Kanazawa A, Ehara K, Kinugasa Y, Kinoshita T, Nomura A, Kitagawa Y. Assessment of the Safety of the New Hybrid Pencil Type Energy (NP) Device Used Close to the Recurrent Laryngeal Nerve in a Porcine Model: Comparison With a Conventional Electrosurgical Knife. Surg Innov. 2019;26(2):219-26.
Liu H, Kinoshita T, Tonouchi A, Kaito A, Tokunaga M. What are the reasons for a longer operation time in robotic gastrectomy than in laparoscopic gastrectomy for stomach cancer? Surg Endosc. 2019;33(1):192-8.
Kaito A, Kuwata T, Tokunaga M, Shitara K, Sato R, Akimoto T, Kinoshita T. HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer. World J Clin Cases. 2019;7(15):1964-77.
Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, Sato E, Fukuoka S, Tada Y, Tanaka A, Morikawa H, Kawazoe A, Kinoshita T, Shitara K, Sakaguchi S, Nishikawa H. PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer. Proc Natl Acad Sci U S A. 2019;116(20):9999-10008.
Katai H, Mizusawa J, Katayama H, Kunisaki C, Sakuramoto S, Inaki N, Kinoshita T, Iwasaki Y, Misawa K, Takiguchi N, Kaji M, Okitsu H, Yoshikawa T, Terashima M. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401. Gastric Cancer. 2019;22(5):999-1008.
Oono Y, Kuwata T, Takashima K, Shinmura K, Hori K, Yoda Y, Ikematsu H, Shitara K, Kinoshita T, Yano T. Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples. Gastric Cancer. 2019;22(2):335-43.
Wakabayashi T, Abe Y, Kanazawa A, Oshima G, Kodai S, Ehara K, Kinugasa Y, Kinoshita T, Nomura A, Kawakubo H, Kitagawa Y. Feasibility Study of a Newly Developed Hybrid Energy Device Used During Laparoscopic Liver Resection in a Porcine Model. Surg Innov. 2019;26(3):350-8.
Tonouchi A, Kinoshita T, Watanabe M, Sugita S, Kaito A, Tokunaga M. Laparoscopic total gastrectomy for gastric cancer with adult intestinal malrotation: a case report. Dig Med Res. 2018;1:6.
Watanabe M, Kinoshita T, Morita S, Yura M, Tokunaga M, Otsuki S, Yamagata Y, Kaito A, Yoshikawa T, Katai H. Clinical impact of splenic hilar dissection with splenectomy for gastric stump cancer. Eur J Surg Oncol. 2019;45(8):1505-10.
Watanabe M, Kinoshita T, Tokunaga M, Kaito A, Sugita S. Complications and their correlation with prognosis in patients undergoing total gastrectomy with splenectomy for treatment of proximal advanced gastric cancer. Eur J Surg Oncol. 2018;44(8):1181-5.
Oono Y, Kuwata T, Takashima K, Yoda Y, Ikematsu H, Shitara K, Kinoshita T, Yano T. Clinicopathological features and endoscopic findings of HER2-positive gastric cancer. Surg Endosc. 2018;32(9):3964-71.
Fukagawa T, Katai H, Mizusawa J, Nakamura K, Sano T, Terashima M, Ito S, Yoshikawa T, Fukushima N, Kawachi Y, Kinoshita T, Kimura Y, Yabusaki H, Nishida Y, Iwasaki Y, Lee SW, Yasuda T, Sasako M. A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A). Gastric Cancer. 2018;21(1):68-73.
Sugita S, Kinoshita T, Kaito A, Watanabe M, Sunagawa H. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction. Surg Endosc. 2018;32(1):383-90.
Terada M, Kinoshita T, Kaito A, Sugita S, Watanabe M, Hayashi R. Evaluation of the prognostic factors in patients with pT3N0 or pT1N2-3 gastric cancer: a single institutional retrospective cohort study. Surg Today. 2018;48(3):325-32.
Tokunaga M, Kaito A, Sugita S, Watanabe M, Sunagawa H, Kinoshita T. Robotic gastrectomy for gastric cancer. Transl Gastroenterol Hepatol 2017;2(6).
Sunagawa H, Kinoshita T, Kaito A, Shibasaki H, Kaneko K, Ochiai A, Ohtsu A, Nishida T. Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer: a retrospective analysis of 200 cases. Surg Today. 2017;47(2):202-9.
Sunagawa H, Kinoshita T. Three-dimensional computed tomography simulation for laparoscopic lymph node dissection in the treatment of proximal gastric cancer. Transl Gastroenterol Hepatol. 2017;2(5).
Abe I, Kinoshita T, Kaito A, Sunagawa H, Watanabe M, Sugita S, Tonouchi A, Sato R. Five-year Survival Associated with Stage I Gastric Cancer after Resection of Early Recurrence at Nodal Station No. 14v: a Case Report. J Gastric Cancer. 2017;17(2):186-91.
Aizawa M, Honda M, Hiki N, Kinoshita T, Yabusaki H, Nunobe S, Shibasaki H, Matsuki A, Watanabe M. Oncological outcomes of function-preserving gastrectomy for early gastric cancer: a multicenter propensity score matched cohort analysis comparing pylorus-preserving gastrectomy versus conventional distal gastrectomy. Gastric Cancer. 2017;20(4):709-17.
Higaki E, Yanagi S, Gotohda N, Kinoshita T, Kuwata T, Nagino M, Ochiai A, Fujii S. Intraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resection. Cancer Sci. 2017;108(5):978-86.
Ito S, Sano T, Mizusawa J, Takahari D, Katayama H, Katai H, Kawashima Y, Kinoshita T, Terashima M, Nashimoto A, Nakamori M, Onaya H, Sasako M. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. Gastric Cancer. 2017;20(2):322-31.
Kaito A, Kinoshita T, Shitara K, Shibasaki H, Nishida T. Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery. Eur J Surg Oncol. 2017;43(4):801-7.
Kaito A, Kinoshita T, Tokunaga M, Sunagawa H, Watanabe M, Sugita S, Tonouchi A, Sato R, Abe I, Akimoto T. Prognostic Factors and Recurrence Pattern of Far-advanced Gastric Cancer with Pathologically-positive Para-aortic Lymph Nodes. Anticancer Research. 2017;37(7):3685-92.
Kataoka K, Kinoshita T, Moehler M, Mauer M, Shitara K, Wagner AD, Schrauwen S, Yoshikawa T, Roviello F, Tokunaga M, Boku N, Ducreux M, Terashima M, Lordick F. Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG. Gastric Cancer. 2017;20(5):904-12.
Watanabe M, Kinoshita T, Enomoto N, Shibasaki H, Nishida T. Clinical Significance of Splenic Hilar Dissection with Splenectomy in Advanced Proximal Gastric Cancer: An Analysis at a Single Institution in Japan. World J Surg. 2016;40(5):1165-71.
Higaki E, Kuwata T, Nagatsuma AK, Nishida Y, Kinoshita T, Aizawa M, Nitta H, Nagino M, Ochiai A. Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method. Gastric Cancer. 2016;19(1):63-73.
Honda M, Hiki N, Kinoshita T, Yabusaki H, Abe T, Nunobe S, Terada M, Matsuki A, Sunagawa H, Aizawa M, Healy MA, Iwasaki M, Furukawa TA. Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study. Ann Surg. 2016;264(2):214-22.
Kataoka K, Katai H, Mizusawa J, Katayama H, Nakamura K, Morita S, Yoshikawa T, Ito S, Kinoshita T, Fukagawa T, Sasako M. Non-Randomized Confirmatory Trial of Laparoscopy-Assisted Total Gastrectomy and Proximal Gastrectomy with Nodal Dissection for Clinical Stage I Gastric Cancer: Japan Clinical Oncology Group Study JCOG1401. J Gastric Cancer. 2016;16(2):93-7.
Tonouchi A, Kinoshita T, Sunagawa H, Hamakawa T, Kaito A, Shibasaki H, Kuwata T, Seki Y, Nishida T. Bronchogenic cyst at esophagogastric junction treated by laparoscopic full-thickness resection and hand-sewn closure: a case report. Surg Case Rep. 2016;2(1):41.
Fujii S, Fujihara A, Natori K, Abe A, Kuboki Y, Higuchi Y, Aizawa M, Kuwata T, Kinoshita T, Yasui W, Ochiai A. TEM1 expression in cancer-associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer. Cancer Med. 2015;4(11):1667-78.
Nishida Y, Kuwata T, Nitta H, Dennis E, Aizawa M, Kinoshita T, Ohtsu A, Ochiai A. A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity. Gastric Cancer. 2015;18(3):458-66.
Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Honda M, Kaito A, Daiko H, Kinoshita T. Recurrence Patterns of Esophagogastric Junction Adenocarcinoma According to Siewert's Classification After Radical Resection. Anticancer Research. 2014;34(8):4391-7.
Hosokawa Y, Konishi M, Sahara Y, Kinoshita T, Takahashi S, Gotohda N, Kato Y, Kinoshita T. Limited subtotal gastrectomy for early remnant gastric cancer. Gastric Cancer. 2014;17(2):332-6.
Nakayama Y, Gotohda N, Shibasaki H, Nomura S, Kinoshita T, Hayashi R. Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer. Surg Today. 2014;44(11):2146-52.
Fujita T, Gotohda N, Kato Y, Kinoshita T, Takahashi S, Konishi M, Daiko H, Nishimura M, Kuwata T, Ochiai A, Kinoshita T. Clinicopathological features of stomach cancer with invasive micropapillary component. Gastric Cancer. 2012;15(2):179-87.
Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T. Clinicopathological Features and Prognostic Factors of Adenocarcinoma of the Esophagogastric Junction According to Siewert Classification: Experiences at a Single Institution in Japan. Ann Surg Oncol. 2012;19(2):677-83.